Research Chemicals Cabergoline: Uses, Data, and Safety in the Lab

Research chemicals cabergoline is a dopamine agonist studied for prolactin and dopamine pathways. Learn its research uses, dosing data, and safety concerns.

ARTICLE OVERVIEW

Research chemicals cabergoline is a dopamine agonist studied for prolactin and dopamine pathways. Learn its research uses, dosing data, and safety concerns.

Cabergoline is a long-acting dopamine D2 receptor agonist that some vendors sell as a research chemical even though it is an FDA-approved prescription drug in the United States. In laboratory settings, researchers use it to study prolactin suppression, dopamine signaling, and dopamine-linked behaviors in animal and cell models. Cabergoline is not approved for human consumption when purchased from research chemical suppliers, and it should only be handled by trained personnel in a controlled lab environment.

What Is Cabergoline and Why Is It Sold as a Research Chemical?

Cabergoline, sometimes abbreviated CABE, belongs to the ergot-derived dopamine agonist family. The FDA approved it in 1996 under the brand name Dostinex for treating hyperprolactinemia, and clinicians also use it off-label for Parkinson's disease and pituitary adenomas.

Vendors market it as a research chemical because the term describes a marketing and legal category, not a pharmacological one. A compound shipped with a "not for human consumption" label can still be a regulated prescription medicine.

Many scientists order cabergoline through pharmaceutical or analytical reference suppliers instead of a research chemicals list, because purity documentation and chain-of-custody records matter for reproducible results.

How Cabergoline Works: D2/D3 Activity and Prolactin

Cabergoline binds with high affinity to dopamine D2 receptors and, to a lesser degree, D3 and 5-HT2B receptors. Activating D2 receptors on lactotroph cells in the anterior pituitary suppresses prolactin release.

Its long half-life of roughly 63 to 68 hours in humans, with some estimates extending past 100 hours, makes it useful in chronic dosing studies where steady-state receptor occupancy is required.

Preclinical researchers also examine cabergoline for its effects on:

  • Striatal dopamine turnover and motor behavior in rodent models
  • Prolactinoma cell proliferation in vitro
  • Reward pathways and compulsive behavior paradigms
  • Cardiac 5-HT2B signaling, a documented safety concern at high cumulative doses

Common Research Applications

Cabergoline appears across several preclinical disciplines. It is most common in neuroendocrinology, behavioral pharmacology, and translational Parkinson's research.

  1. Prolactin suppression studies: used to model the reversal of drug-induced hyperprolactinemia.
  2. Dopamine agonist comparisons: used as a long-acting reference compound against shorter-acting agonists.
  3. Behavioral pharmacology: tested in locomotion, yawning, and reward-devaluation tasks.
  4. Cardiotoxicity screening: its 5-HT2B agonist activity makes it a control compound in valvulopathy research.

Cabergoline vs Other Dopamine Agonists

Choosing a dopamine agonist for a study depends on receptor selectivity, half-life, and the model system. The table below compares compounds frequently run alongside cabergoline.

CompoundPrimary targetsApprox. half-lifeTypical research focus
CabergolineD2, D3, 5-HT2B63–68 hoursProlactin suppression, chronic dosing, valvulopathy controls
BromocriptineD2, partial D13–6 hoursAcute prolactin models, motor behavior
PramipexoleD2, D38–12 hoursParkinson's models, neuroprotection
RopiniroleD2, D36 hoursMotor function, restless legs models
QuinagolideD211–17 hoursProlactin research, non-ergot comparisons

Cabergoline's main advantage in research is duration: one dose can maintain D2 occupancy for days in vivo, which reduces handling stress in animal protocols. Its main drawback is 5-HT2B activity, which is linked to cardiac valve changes during long-term human use.

Handling, Solubility, and Storage

Cabergoline is typically supplied as a white to off-white crystalline powder. It dissolves in ethanol and DMSO and is only slightly soluble in water, so most protocols use a co-solvent or suspension vehicle.

  • Storage: keep powder dry and protected from light, at -20 °C for long-term storage.
  • Stock solutions: prepare in DMSO or ethanol and aliquot to avoid repeated freeze-thaw cycles.
  • Rodent doses reported in literature: commonly 0.1–1 mg/kg, given subcutaneously or intraperitoneally.
  • Human clinical doses: 0.25–1 mg once or twice weekly, strictly under prescription.

Any lab working with cabergoline should follow institutional chemical safety rules, wear gloves and eye protection, and document batch identity. Suppliers of chemicals for research usually include a certificate of analysis, but researchers should still confirm purity in-house with HPLC or LC-MS.

Cabergoline is a prescription-only medicine in the United States, the European Union, and most other jurisdictions. Labeling it "not for human consumption" does not change its regulatory status, and importing it for personal use is illegal in the US.

Legitimate laboratories buy cabergoline from pharmaceutical or analytical reference suppliers rather than consumer-facing shops. When browsing a research chemicals usa vendor site, treat any cabergoline listing as a prompt to examine the supplier's documentation and legal disclaimers closely.

Researchers comparing catalogs across research chemicals europe will notice similar labeling practices, since EU regulators also classify cabergoline as a prescription drug. Certain advanced research chemicals suppliers market it for receptor-binding assays, which is a valid in vitro use but never a basis for human consumption.

Cabergoline is not a novel designer compound with an unknown profile. It is a regulated pharmaceutical with documented cardiac, psychiatric, and hormonal side effects.

Reported adverse effects in humans include nausea, dizziness, impulse-control disorders, and, with long-term high-dose use, cardiac valvular fibrosis. Anyone considering cabergoline for a clinical purpose should consult a licensed healthcare professional, because self-dosing with a research chemical is dangerous and unsupported by regulatory oversight.

Frequently Asked Questions

Is cabergoline a research chemical or a prescription drug?

Cabergoline is an FDA-approved prescription drug sold under the brand name Dostinex. Some vendors market it as a research chemical, but that label does not change its legal status or its approved clinical uses. In the US, it requires a prescription.

What is cabergoline used for in research?

In preclinical research, cabergoline is used to study dopamine D2 receptor signaling, prolactin suppression, and motor behavior. It also serves as a long-acting reference compound in Parkinson's models and in cardiotoxicity research tied to 5-HT2B activity.

Can you legally buy cabergoline in the United States?

No. Cabergoline requires a prescription in the United States, and importing it for personal use is illegal. Legitimate laboratories purchase it from pharmaceutical or analytical reference suppliers that provide proper documentation and certificates of analysis.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.